A reappraisal of brush cytology for screening of Barrett's esophagus

Endoscopy

Volumn 42, Issue 10, 2010, Pages 864-865

  Pacha, A F ^a   Krishnadath, K K ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; PROTEIN P53;

ANEUPLOIDY; BARRETT ESOPHAGUS; BRUSH CYTOLOGY; CYTOLOGY; DISEASE COURSE; DYSPLASIA; EDITORIAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROESOPHAGEAL REFLUX; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; RISK FACTOR; SAMPLING ERROR; SCREENING; SENSITIVITY AND SPECIFICITY;

BARRETT ESOPHAGUS; BIOPSY; CYTODIAGNOSIS; HUMANS;

EID: 77957306690     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0030-1255757     Document Type: Editorial

References (17)

1. Fahmy M, Skacel M, Gramlich T et al. Chromosomal gains and genomic loss of p53 and p16 genes in Barretts esophagus detected by flourescence in situ hybridization of cytology specimens. Modern Pathology 2004 17 588-596
2. Zagorowicz E, Jankowski J. Molecular changes in the progression of Barretts oesophagus. Systematic review of molecular biomarkers, regarding the ASPECT study in the UK. Post Grad Med J 2007 83 529-535
3. Tischoff I, Tannapfel A. Barretts esophagus: can biomarkers predict progression to malignancy? Expert Rev Gastroenterol Hepatol 2008 2 653-663
4. Saad S R., Mahood K L., Clary M K. et al. Role of cytology in the diagnosis of Barretts esophagus and associated neoplasia. Diagn Cytopathol 2003 29 130-135
5. Huang Q, Hardie L J. Biomarkers in Barretts oesophagus. Biochemical Society Transaction 2010 38 343-347
6. Spechler S J. Clinical practice. Barretts Esophagus. N Engl J Med 2002 346 836-842
7. Kumaravel A, Lopez R, Brainard J, Falk G W. Brush cytology vs. endoscopic biopsy for the surveillance of Barretts esophagus. Endoscopy 2010 10 800-805
8. Geisinger K R., Teot L A., Richter J E. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barretts esophagus. Cancer 1992 69 8-16
9. Robey S S., Hamilton S R., Gupta P K., Erozan Y S. Diagnostic value of cytopathology in Barrett esophagus and associated carcinoma. Am J Clin Pathol 1988 89 493-498
10. Hardwick R H., Morgan R J., Warren B F. et al. Brush cytology in the diagnosis of neoplasia in Barretts esophagus. Dis Esophagus 1997 10 233-237
11. Fritcher E G., Brankley S M., Kipp B R. et al. A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barretts esophagus. Hum Pathol 2008 39 1128-1135
12. Falk G W. Cytology in Barretts esophagus. Gastrointest Endosc Clin N Am 2003 13 335-348
13. Falk G W., Chittajallu R, Goldblum J R. et al. Surveillance of patients with Barretts esophagus for dysplasia and cancer with balloon cytology. Gastroenterology 1997 112 1787-1797
14. Brankley S, Wang K K., Harwood A R. et al. The development of a flourescence in situ hybridisation assay for the detection of dysplasia and adenocarcinoma in Barretts esophagus. J Mol Diagn 2006 8 260-267
15. Rygiel A, van Baal W, Milano F et al. Efficient automated assessment of genetic abnormalities detected by flourescent in situ hybridization on brush cytology of a Barretts esophagus surveillance population. Cancer 2007 109 1980-1988
16. Rygiel A, van Baal W, Milano F et al. Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barretts esophagus brush cytology specimens. Genes Chromosomes Cancer 2008 47 396-404
17. Kerkhof M, Kusters J, van Dekken H et al. Biomarkers for risk stratification of neoplastic progression in Barrett esophagus. Cell Oncol 2007 29 507-517